Selected data models

You must log in to select data models for download or further analysis.

48 Search results.
Relevance Rating New first Old first

Eligibility Pulmonary Arterial Hypertension NCT00709956

- 9/27/21 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Iloprost Power 15 in Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00709956

Eligibility Pulmonary Arterial Hypertension NCT00617305

- 9/27/21 - 1 form, 1 itemgroup, 17 items, 1 language
Itemgroup: Criteria
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1); ODM derived from: https://clinicaltrials.gov/show/NCT00617305

Eligibility Pulmonary Arterial Hypertension NCT02032836

- 9/17/21 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparative PK PD Study in PAH Patients (Fox vs. I-Neb); ODM derived from: https://clinicaltrials.gov/show/NCT02032836

Eligibility Pulmonary Arterial Hypertension NCT02234141

- 9/17/21 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
GS-4997 in Adults With Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT02234141

Eligibility Pulmonary Arterial Hypertension NCT01841762

- 6/23/21 - 1 form, 2 itemgroups, 28 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT; ODM derived from: https://clinicaltrials.gov/show/NCT01841762

Eligibility Suspected Arterial Hypertension NCT01278732

- 4/19/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mass; ODM derived from: https://clinicaltrials.gov/show/NCT01278732

Eligibility Pulmonary Arterial Hypertension NCT02516722

- 6/26/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
TReatment Of Pulmonary HYpertension 1 Study; ODM derived from: https://clinicaltrials.gov/show/NCT02516722

Eligibility Pulmonary Arterial Hypertension NCT02080533

- 6/25/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT02080533

Eligibility Pulmonary Arterial Hypertension NCT02060487

- 6/25/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effects of Oral Sildenafil on Mortality in Adults With PAH; ODM derived from: https://clinicaltrials.gov/show/NCT02060487

Eligibility Pulmonary Arterial Hypertension NCT01934582

- 1/17/19 - 1 form, 2 itemgroups, 8 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol; ODM derived from: https://clinicaltrials.gov/show/NCT01934582

Eligibility Pulmonary Arterial Hypertension NCT01553721

- 1/17/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH); ODM derived from: https://clinicaltrials.gov/show/NCT01553721

Eligibility Pulmonary Arterial Hypertension NCT01468545

- 1/17/19 - 1 form, 2 itemgroups, 8 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System; ODM derived from: https://clinicaltrials.gov/show/NCT01468545

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial